Advantage Alpha Capital Partners LP Reduces Stock Position in Definitive Healthcare Corp. (NASDAQ:DH)

Advantage Alpha Capital Partners LP lessened its position in Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 86.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 58,505 shares of the company's stock after selling 363,941 shares during the quarter. Advantage Alpha Capital Partners LP owned approximately 0.05% of Definitive Healthcare worth $262,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Intech Investment Management LLC purchased a new stake in shares of Definitive Healthcare during the third quarter worth $55,000. Sanctuary Advisors LLC purchased a new stake in Definitive Healthcare during the 2nd quarter worth about $85,000. Bleakley Financial Group LLC acquired a new stake in Definitive Healthcare in the 3rd quarter valued at about $74,000. SG Americas Securities LLC purchased a new position in shares of Definitive Healthcare in the 3rd quarter valued at about $84,000. Finally, Canada Pension Plan Investment Board acquired a new position in shares of Definitive Healthcare during the second quarter worth about $109,000. Institutional investors and hedge funds own 98.67% of the company's stock.

Definitive Healthcare Stock Performance

Shares of Definitive Healthcare stock traded down $0.02 during trading hours on Wednesday, hitting $4.66. 252,913 shares of the company were exchanged, compared to its average volume of 740,624. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33. The business has a 50-day moving average of $4.35 and a 200-day moving average of $4.79. Definitive Healthcare Corp. has a 1 year low of $3.19 and a 1 year high of $10.62. The stock has a market capitalization of $538.32 million, a price-to-earnings ratio of -1.50, a P/E/G ratio of 3.28 and a beta of 1.33.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on DH. Stifel Nicolaus decreased their price target on shares of Definitive Healthcare from $9.50 to $7.50 and set a "buy" rating for the company in a research note on Wednesday, July 31st. BTIG Research began coverage on shares of Definitive Healthcare in a research note on Tuesday, September 17th. They set a "buy" rating and a $7.00 target price for the company. JPMorgan Chase & Co. lowered Definitive Healthcare from a "neutral" rating to an "underweight" rating and cut their target price for the stock from $7.00 to $5.00 in a research report on Wednesday, July 31st. Barclays reduced their price target on shares of Definitive Healthcare from $6.00 to $4.00 and set an "equal weight" rating for the company in a research report on Wednesday, August 7th. Finally, Deutsche Bank Aktiengesellschaft dropped their price target on Definitive Healthcare from $7.00 to $5.00 and set a "hold" rating on the stock in a research note on Friday, August 9th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $5.81.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.